Blood Purification

Case Report

Identification of Complex Pneumonia during the Outbreak of COVID-19: Bacterial Pneumonia Combined with Acute Eosinophilic Pneumonia in Patients with Maintenance Hemodialysis

Hu Q.a · Mao N.b · Huang X.a · Chen D.a · Zhang Q.a

Author affiliations

aDepartment of Nephrology, The Affiliated Traditional Chinese Medicine (TCM) Hospital of Southwest Medical University, Luzhou, China
bDepartment of Nephrology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China

Related Articles for ""

Blood Purif 2021;50:132–136

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: March 27, 2020
Accepted: June 28, 2020
Published online: July 28, 2020
Issue release date: January 2021

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU

Abstract

It is of crucial importance to diagnose patients in a timely and clear manner during the outbreak of COVID-19. Different causes of pneumonia makes it difficult to differentiate COVID-19 from others. Hemodialysis patients are a special group of people in this outbreak. We present a successfully treated case of a patient with maintenance hemodialysis from acute eosinophilic pneumonia for using meropenem when treating bacterial pneumonia, avoiding possible panic and waste of quarantine materials in dialysis centers.

© 2020 S. Karger AG, Basel


References

  1. Word Health Organizaion [Internet]. COVID-19 outbreak declared to be a Public Health emergency of international concern (PHEIC). 2020
  2. General Office of the National Health Commission of China Published [Internet]. Guidance on treating COVID-19 (Draft Version VI). 2020 http://www.nhc.gov.cn/yzygi/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.
  3. Kara PH, Urnal R, Unluer EE. A must diagnosis of persistent cough: chronic eosinophilic pneumonia (Carrington disease). Am J Emerg Med. 2016;34(8):1734–6.
    External Resources
  4. Bernheim A, McLoud T. A review of clinical and imaging findings in eosinophilic lung diseases. AJR Am J Roentgenol. 2017;208(5):1002–10.
    External Resources
  5. De Giacomi F, Decker PA, Vassallo R, Ryu JH. Acute eosinophilic pneumonia: correlation of clinical characteristics with underlying cause. Chest. 2017;152(2):379–85.
    External Resources
  6. Mehrian P, Doroudinia A, Rashti A, Aloosh O, Dorudinia A. High-resolution computed tomography findings in chronic eosinophilic vs. cryptogenic organising pneumonia. Int J Tuberc Lung Dis. 2017;21(11):1181–6.
    External Resources
  7. Jin Y-H, Cai L, Cai L, Cheng Z-S, Cheng H, Deng T, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.
    External Resources
  8. General Office of the National Health Commission of China Published [Internet]. Guidance on treating COVID-19 (Draft Version VII). 2020 http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
  9. Funda Y, Zafer HAS, Nurefsan B, Mehmet G. A chronic eosinophilic pneumonia case with long exposure to isocyanates. J Pak Med Assoc. 2014;64(10):1191–4.
  10. Nakayasu H, Shirai T, Tanaka Y , Y, Saigusa M. Chronic eosinophilic pneumonia after radiation therapy for squamous cell lung cancer. Respir Med Case Rep. 2017;22:147–9.
    External Resources
  11. The U.S. Food and Drug Administration Published [Internet]. FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin). 2010 https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin.
  12. You GH, Jia L. Summary and data analysis of foreign cases of minocycline-induced acute eosinophilic granulocytes. Chin J New Drugs. 2017;26(13):1590–4.
  13. Hatem NA, Campbell S, Rubio E, Loschner AL. Meropenem: a possible new culprit in eosinophilic lung diseases. Lung India. 2017;34(5):461–4.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: March 27, 2020
Accepted: June 28, 2020
Published online: July 28, 2020
Issue release date: January 2021

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP